These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14679455)
1. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Nuermberger E; Bishai WR Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455 [TBL] [Abstract][Full Text] [Related]
2. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Rothermel CD Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368 [TBL] [Abstract][Full Text] [Related]
3. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306 [TBL] [Abstract][Full Text] [Related]
4. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. Farrell DJ; Jenkins SG J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832 [TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Lynch III JP; Martinez FJ Clin Infect Dis; 2002 Mar; 34 Suppl 1():S27-46. PubMed ID: 11810608 [TBL] [Abstract][Full Text] [Related]
9. Macrolide and ketolide resistance with Streptococcus pneumoniae. Doern GV Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K; J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of macrolide resistance in community-acquired respiratory tract infections. Hoban DJ; Zhanel GG Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS). Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038 [No Abstract] [Full Text] [Related]
14. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP; Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522 [TBL] [Abstract][Full Text] [Related]
15. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era. Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of antibiotic resistance in respiratory tract infections. Klugman KP Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654 [TBL] [Abstract][Full Text] [Related]
17. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea. Bae S; Lee K Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840 [TBL] [Abstract][Full Text] [Related]
18. Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Low DE Clin Infect Dis; 2004 May; 38 Suppl 4():S357-62. PubMed ID: 15127370 [TBL] [Abstract][Full Text] [Related]
19. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Gulay Z; Ozbek OA; Bicmen M; Gur D Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364 [TBL] [Abstract][Full Text] [Related]